MAGENTIQ-COLO (ME-APDS)
Overview
MAGENTIQ-COLO (ME-APDS) is an AI-powered software solution designed to assist gastroenterologists in real-time during colonoscopy procedures. Utilizing advanced deep learning, computer vision, and video analysis technologies, the system identifies and highlights suspicious gastrointestinal lesions, such as polyps, on the video output from the colonoscope. This real-time assistance aims to significantly improve the adenoma detection rate (ADR) and reduce the adenoma miss rate (AMR), thereby contributing to the early detection and prevention of colorectal cancer (CRC).
The platform integrates computer-aided detection (CADe) for real-time polyp identification and, in its CE-marked versions available in Europe, offers computer-aided diagnosis (CADx) capabilities for polyp size estimation and characterization. It also includes AI-based quality metrics such as automated Boston Bowel Preparation Score (BBPS) assessment and cecum detection with automatic confirmation and reporting of appendiceal orifice visualization. The system is compatible with leading endoscopy systems, including Sonoscape, Olympus, Fujinon, and Pentax, and can be deployed as a processor-only unit or on a fully equipped portable cart.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Real-time AI-aided polyp detection (CADe)
- Computer-aided diagnosis (CADx) for polyp size and characterization (CE-marked)
- AI-based quality metrics (e.g., BBPS, cecum detection) (CE-marked)
- AI-based endoscopic tool detection (FDA-cleared in US version)
- Automated structured reporting
- High polyp-wise sensitivity (99.6%) and specificity (98%)
- Compatibility with leading endoscopy systems (Sonoscape, Olympus, Fujinon, Pentax)
- Video recording and export capabilities
Use Cases
- Improving adenoma detection rate (ADR) during colonoscopies
- Reducing adenoma miss rate (AMR)
- Early detection and prevention of colorectal cancer (CRC)
- Enhancing overall quality of colonoscopy examinations
- Supporting procedural quality documentation
- Retrospective analysis of colonoscopy videos
What Physicians Need to Know
MAGENTIQ-COLO serves as a valuable real-time adjunct during colonoscopy, enhancing polyp detection and reducing miss rates. Physicians should integrate the AI-highlighted areas into their visual assessment, understanding that the system is an aid and not a replacement for clinical judgment or histopathological sampling. Utilizing the automated documentation features for bowel preparation and cecum detection can streamline reporting and improve quality metrics. The real-time display of polyp size and type can further inform immediate decision-making during the procedure.
MAGENTIQ-COLO is designed for seamless integration into existing endoscopy workflows. It connects to standard endoscopy towers (Olympus, Fujinon, Pentax, Sonoscape) to acquire video signals, displaying its AI-enhanced output on a dedicated or main screen. This allows for easy adoption without requiring significant changes to current equipment or procedural steps.
Details
| Category | Gastroenterology AI, Oncology AI |
| Pricing | Subscription-based (monthly rental) — Monthly rental business model; Low upfront cost; Flexible commitment; Automatic software updates |
| Deployment | On-premise computing device that acquires digital video output signals from local endoscopy tower; available as processor-only unit or on a portable cart with touchscreen. |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
1 AI-estimated MAGENTIQ-COLO received FDA 510(k) clearance in July 2023 for its AI-aided software for real-time detection of gastrointestinal lesions during colonoscopy. A modified version also received 510(k) clearance in January 2025, confirming it is as safe and effective as the prior cleared device. |
| Integrations | |
| EHR | Not specified |
| Specialties | Gastroenterology |
What the Web Says
MAGENTIQ-COLO (ME-APDS) is an AI-powered computer-aided detection system designed to assist physicians during colonoscopies by identifying potential mucosal abnormalities and polyps in real-time. Clinical studies, including a large international multicenter trial published in The Lancet Digital Health, have shown that MAGENTIQ-COLOu2122 significantly increases adenoma detection rates (ADR) and decreases adenoma miss rates (AMR). The system has received FDA pre-market approval and CE Mark, and is recognized for its ability to enhance the quality of colonoscopy procedures and potentially reduce the risk of colorectal cancer.
Overall: PositiveStrengths
- Increases Adenoma Detection Rate (ADR) significantly (e.g., 7% absolute, 26% relative increase).
- Decreases Adenoma Miss Rate (AMR) substantially (e.g., 17% absolute, 47-48% relative decrease).
- Aids in early detection of colorectal cancer and other gastrointestinal diseases.
- Works in real-time with standard white-light endoscopy imaging, highlighting suspicious areas without altering the video stream.
- More precise with subtle, low-contrast lesions and produces fewer distracting false positives compared to other AI platforms.
- Easy to use and integrates well into existing clinical workflows, providing additional information like polyp size and type.
Limitations
- Some physicians express mixed feelings, noting that while helpful for subtle polyps, it may not significantly change practice for experienced endoscopists with high ADRs.
- Potential for over-reliance on AI tools, which could lead to a drop in ADR if the tool is not available.
- One Reddit discussion on a different AI system for polyp detection in Poland showed a decrease in ADR after AI integration, raising questions about real-world effectiveness and potential deskilling.
- The system is not a diagnostic tool and does not replace histopathological sampling or clinical decision-making.
- Limited to use with standard white-light endoscopy imaging.
Based on reviews from: AI/ML: Magentiq Eye Automatic Polyp Detection System (ME-APDS), Magentiq's AI-aided colonoscopy tool increases adenoma detection by 7%, MAGENTIQ EYEu2013 AI aided colonoscopy, Magentiq Eye Reviews, Pricing, Features & Integrations - Elion Health, A new benchmark for AI aided colonoscopy - magentiq eye, January 24, 2025 Magentiq Eye LTD John J. Smith Partner Hogan Lovells US LLP Columbia Square 555 13th Street, NW Washington, - accessdata.fda.gov, MAGENTIQ-COLO for Colonoscopy u00b7 Info for Participants - Clinical Trials, Lancet Digital Health Study Confirms MAGENTIQ-COLOu2122 AI-aided Colonoscopy Technology Improves Adenoma Detection Rates, The colonoscopy magic eye: novel software detects missed lesions - CORDIS, AI-Aided Colonoscopy Technology: Dror Zur from Magentiq Eye in a Dialogue Exchange with PharmaShots, Is Artificial Intelligence the future of colonoscopy? - magentiq eye, NICE backs five AI tools for bowel cancer screening - pharmaphorum, AI/ML: Magentiq Eye's Automatic Polyp Detection System (ME-APDS), FDA Authorizes Marketing of MAGENTIQ-COLOu2122, a Cutting-Edge AI Gastrointestinal Lesion Software Detection System that Helps Detect Lesions in Real Time During Colonoscopy Procedures - BioSpace, Anyone here worked with or for MagentIQ? : r/buhaydigital - Reddit, NCT04640792 | A Study to Evaluate the Safety and Efficacy of the Use of ME-APDS During Colonoscopy | ClinicalTrials.gov, Lancet Digital Health Study Confirms MAGENTIQ-COLOu2122 AI-aided Colonoscopy Technology Improves Adenoma Detection Rates - BioSpace, AI aided colonoscopy - MAGENTIQ-COLO - Duomed, MAGENTIQ EYE Releases New MAGENTIQ-COLO(TM) Versions Expanding User Experience and AI-Based Quality Metrics in Colonoscopy | Newswire, Lancet Digital Health Study Confirms MAGENTIQ-COLOu2122 AI-aided Colonoscopy Technology Improves Adenoma Detection Rates - PR Newswire, AI improves adenoma detection in colonoscopies - pharmaphorum, GI doctors, have you ever used an AI tool, and what are your thoughts on AI-assisted endoscopy? : r/Gastroenterology - Reddit, UrgentIQ Software Pricing, Alternatives & More 2026 | Capterra, After exposure to artificial intelligence, diagnostic colonoscopy polyp detection rates in four Polish medical centers decreased from 28.4% to 22.4% : r/science - Reddit
Last updated: 2026-07-20
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate MAGENTIQ-COLO (ME-APDS)
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for MAGENTIQ-COLO (ME-APDS).
Frequently Asked Questions
Investors who backed MAGENTIQ-COLO (ME-APDS)
Funded through the company that built this tool.
